OSUR OraSure Technologies, Inc.
$3.25▲ +0.62%
Healthcare
Other
After hours
$3.25▲ +0.00%
Sep 11, 7:30 PM ET
Volume 467.3K
Avg Volume (10D) 379.7K
Key Metrics & Fundamentals
Market Cap
$224.15M
P/E Ratio
–
Div Yield
–%
52W Range
2.08 - 4.58
% vs 50 MA
-16.43%
% vs 200 MA
-0.86%
RSI-14
28.0
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.15
Free Cash Flow
-$12.35M
Gross Rev
$30.64M
Gross Profit
$13.32M
EBITDA
-$37.47M
COGS
$17.32M
Operating Exp
$30.47M
Operating Income
-$17.15M
EBIT
-$17.15M
Pretax Income
$6.82M
Net Income
$6.25M
EPS (Diluted)
0.09
Price & Volume History
Loading chart…
Recent News
OraSure (OSUR) Returns To Profit, But Growth Remains Elusive
Insider Monkey · Sep 6, 2026 11:48 AM
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
PR Newswire · Aug 19, 2026 8:30 PM
OraSure (OSUR) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 13, 2026 12:15 AM
OraSure Technologies, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 6, 2026 12:30 PM
OraSure Technologies Inc (OSUR) (Q2 2026) Earnings Call Highlights: Revenue Surges 9. ...
GuruFocus.com · Aug 6, 2026 5:04 AM
OraSure Technologies Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 4:03 AM
OraSure: Q2 Earnings Snapshot
Associated Press · Aug 5, 2026 9:53 PM
OraSure Announces Second Quarter 2026 Financial Results
GlobeNewswire · Aug 5, 2026 8:05 PM
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
GlobeNewswire · Jul 22, 2026 8:10 PM
OraSure Gets US FDA Emergency Use Authorization for Second Generation Ebola Test
MT Newswires · Jul 21, 2026 9:00 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See OSUR's money flow as a full page
Social Sentiment
No Reddit posts found for OSUR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.